HBK Investments L P Purchases New Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

HBK Investments L P acquired a new position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 20,811 shares of the company's stock, valued at approximately $273,000.

A number of other institutional investors have also made changes to their positions in the business. Oberweis Asset Management Inc. bought a new position in shares of Pediatrix Medical Group in the fourth quarter worth about $6,122,000. Hancock Whitney Corp bought a new position in shares of Pediatrix Medical Group in the fourth quarter worth about $160,000. Price T Rowe Associates Inc. MD increased its stake in shares of Pediatrix Medical Group by 9.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 77,393 shares of the company's stock worth $1,016,000 after purchasing an additional 6,753 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after purchasing an additional 5,104 shares during the period. Finally, MetLife Investment Management LLC increased its stake in shares of Pediatrix Medical Group by 6.8% in the fourth quarter. MetLife Investment Management LLC now owns 53,552 shares of the company's stock worth $703,000 after purchasing an additional 3,419 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Price Performance

Shares of MD traded up $0.11 during mid-day trading on Monday, reaching $12.36. The company had a trading volume of 483,836 shares, compared to its average volume of 840,193. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The company has a market capitalization of $1.06 billion, a P/E ratio of -10.30, a P/E/G ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The company's 50-day moving average is $14.01 and its 200-day moving average is $13.99.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on MD shares. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Truist Financial lowered their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Finally, UBS Group boosted their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research note on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of "Hold" and an average target price of $16.75.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.